A Hemolytic-Uremic Syndrome with the Acquired Immunodeficiency Syndrome
Letters and Corrections1 November 1984A Hemolytic-Uremic Syndrome with the Acquired Immunodeficiency SyndromeRALPH V. BOCCIA, M.D., EDWARD P. GELMANN, M.D., CARL C. BAKER, M.D., Ph.D., GERALD MARTI, M.D., Ph.D., DAN L. LONGO, M.D.RALPH V. BOCCIA, M.D.Search for more papers by this author, EDWARD P. GELMANN, M.D.Search for more papers by this author, CARL C. BAKER, M.D., Ph.D.Search for more papers by this author, GERALD MARTI, M.D., Ph.D.Search for more papers by this author, DAN L. LONGO, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-101-5-716_2 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: The hemolytic-uremic syndrome is a form of microangiopathic hemolytic anemia not previously reported in patients with the acquired immunodeficiency syndrome. We report the case of a patient with the acquired immunodeficiency syndrome and Kaposi's sarcoma who also developed the hemolytic-uremic syndrome.A 33-year-old white homosexual man with the acquired immunodeficiency syndrome and disseminated Kaposi's sarcoma since March 1983 had an initial hemoglobin of 10.4 g/dL; platelet count, 158 000/mm3; blood urea nitrogen, 12 mg/dL; and creatinine, 1.3 mg/dL. Cytomegalovirus was cultured from the semen but not from blood, urine, or pharyngeal washings. Several bone marrow biopsy samples...References1. KIMMILLERMICHEAL YKA. Breakdown products of C3 and factor B in hemolytic-uremic syndrome. J Lab Clin Med. 1977;88:845-51. Google Scholar2. KOSTERLEVINWALKER FJL. Hemolytic-uremic syndrome after shigellosis: relation to endotoxemia and circulating immune complexes. N Engl J Med. 1978;298:927-31. CrossrefMedlineGoogle Scholar3. PAVYWILEYABELOFF MEM. Hemolytic-uremic syndrome associated with mitomycin therapy. Cancer Treat Rep. 1982;66:457-63. MedlineGoogle Scholar4. KRESSELRYANDUONG BKA. Microangiopathic hemolytic anemia, thrombocytopenia, and renal failure in patients treated for adenocarcinoma. Cancer. 1981;48:1738-43. CrossrefMedlineGoogle Scholar5. ANTMANSKARINMAYER KAR. Microangiopathic hemolytic anemia and cancer: a review. Medicine (Baltimore). 1979;58:377-84. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: National Cancer Institute and National Institutes of Health Bethesda, MD 20205 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByThrombotic thrombocytopenic purpura associated with AIDS: challenges in diagnosis and managementDrivers and regulators of humoral innate immune responses to infection and cancerHuman immunodeficiency virus associated thrombotic thrombocytopenic purpura, a clinical conundrumInfection-Associated Thrombotic MicroangiopathyThrombotic Microangiopathy in the Setting of HIV Infection: A Case Report and Review of the Differential Diagnosis and TherapyThrombotic microangiopathy and human immunodeficiency virus in the era of eculizumabThrombotic microangiopathy as an initial manifestation in HIV patientsPostinfectious Hemolytic Uremic SyndromeAdvances in the pathogenesis of HIV-associated kidney diseasesTenofovir Renal Toxicity: Evaluation of Cohorts and Clinical Studies—Part 2Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancerHuman Immunodeficiency Virus Infection and Acute Renal FailureAcute kidney injury in patients with human immunodeficiency virus infectionThrombotic Microangiopathy and Other Glomerular Disorders in the HIV-Infected PatientHAcute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortalityRenal disease in patients with HIVThrombotic Thrombocytopenic Purpura in HIV-Infected PatientsOutcome of Plasma Exchange Therapy in Thrombotic Microangiopathy After Renal TransplantationCurrent concepts in the diagnosis and management of thrombotic thrombocytopenic purpuraLight at the end of the TUNEL: HIV-associated thrombotic microangiopathyThrombotic Microangiopathy in the HIV-2-Infected MacaqueSchistocytosis and a thrombotic microangiopathy-like syndrome in hospitalized HIV-infected patientsThrombotic microangiopathies and HIV infection: Report of two typical cases, features of HUS and TTP, and review of the literatureClinical features and prognostic factors of HIV-associated thrombotic microangiopathiesRenal Complications of Intravenous Drug Abuse and Human Immunodeficiency Virus InfectionThe hemolytic uremic syndrome as a complication of adriamycin nephropathyManifestations Resembling Thrombotic Microangiopathy in Patients with Advanced Human Immunodeficiency Virus (HIV) Disease in a Cytomegalovirus Prophylaxis Trial (ACTG 204)Letter to the EditorThe haemolytic uraemic syndrome in patients with AIDS.The pathophysiology and management of thrombotic thrombocytopenic purpuraMicroangiopathies thrombotiques au cours de l'infection à VIH: quatre observationsThe hemolytic uremic syndromeThrombotic microangiopathy and retroviral infections: A 13-year experienceCase 36-1991Case Report: Cisplatin-lnduced Hemolytic Uremic SyndromeHematologic Abnormalities in AIDSThrombotic Thrombocytopenic Purpura With the Acquired Immunodeficiency Syndrome: A Pathologically Documented Case ReportAcquired Immunodeficiency Syndrome and the KidneyRenal complications of human immunodeficiency virus type 1Human Immunodeficiency Virus (HIV) Infection and the KidneyRichard J. Glassock, MD, Arthur H. Cohen, MD, Gabriel Danovitch, MD, K. Peter Parsa, MDRenal Complications of Human Immunodeficiency Virus-Type IThrombotic MicroangiopathyDelayed renal failure with extensive mesangiolysis following bone marrow transplantationDialysis in the Acquired Immunodeficiency SyndromeMaintenance Dialysis in Patients with Human Immunodeficiency Virus InfectionThrombotic Thrombocytopenic Purpura in a Patient Who Subsequently Developed the Acquired Immunodeficiency Syndrome (AIDS)Anthony C. Botti, MD, Phyllis Hyde, MD, Frank DiPillo, MDThe Clinical Spectrum of Renal Disease Associated With Human Immunodeficiency VirusRenal Syndromes in the Acquired Immunodeficiency Syndrome (AIDS): Lessons Learned from Analysis Over 5 YearsThrombotic thrombocytopenic purpura in human immunodeficiency (HIV)-seropositive malesAcquired Immunodeficiency Syndrome (AIDS) and Sulfadiazine-Associated Acute Renal FailurePETER J. GOADSBY, M.B. B.S., Ph.D., ANTHONY J. DONAGHY, M.B. B.S., ANDREW R. LLOYD, M.B. B.S., DENIS WAKEFIELD, M.D.Thrombotic thrombocytopenic purpura in a human immunodeficiency virus (HIV)-seropositive homosexual manThe Types of Renal Disease in the Acquired Immunodeficiency SyndromeCombination chemotherapy of disseminated kaposi's sarcoma in patients with the acquired immune deficiency syndrome 1 November 1984Volume 101, Issue 5Page: 716-717KeywordsAIDSCreatinineHemoglobinHemolytic anemiaHemolytic-uremic syndromeHomosexualsKaposi sarcomaPlateletsSemenUrine Issue Published: 1 November 1984 PDF DownloadLoading ...